Sort
15,842 grants matching “pancreatic cancer”
Role of Altered Nutrient Metabolism in Pancreatic Cancer
$524,541Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2025 · CA
Multi-Ancestry Mapping of Pancreatic Cancer Susceptibility Loci
$524,504Alison P Klein · Johns Hopkins University · U01 · FY2022 · CA
Sialylation-dependent mechanisms driving pancreatic cancer progression
$524,444Susan L Bellis · University Of Alabama At Birmingham · U01 · FY2019 · CA
The role of regulator of G protein signaling Gbeta5-R7 in neuronal control of body weight
$524,356Vladlen Z Slepak · University Of Miami School Of Medicine · R01 · FY2021 · DK
Advanced Glycation End-Products and Risk of Pancreatic Cancer
$524,349Li Jiao · Baylor College Of Medicine · R01 · FY2013 · CA
MR-HIFU induced drug delivery for pancreatic cancer treatment
$524,312Donghoon Lee · University Of Washington · R01 · FY2019 · CA
Overcoming stromal barriers to therapeutics in pancreas cancer
$524,117Sunil R Hingorani · Fred Hutchinson Cancer Research Center · R01 · FY2011 · CA
Greater Los Angeles Clinical Center of the Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer
$523,936Stephen J Pandol · Cedars-Sinai Medical Center · U01 · FY2020 · DK
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
$523,841Diane M Simeone · University Of California, San Diego · R01 · FY2024 · CA
Accurate Detection of Early-Stage Pancreatic Tumors using Artificial Intelligence Analysis of Abdominal Computed Tomography Scans
$523,670Touseef Ahmad Qureshi · Cedars-Sinai Medical Center · R01 · FY2025 · CA
NETRIN G1 LIGAND: A NEW IMMUNOMODULATORY TARGET AND EARLY BIOMARKER IN PANCREATIC CANCER
$523,663Henry Ford Health System · · FY2025 · Defense Health Agency
Targeting Lymph Node Dependent Immune Tolerance in Cancer
$523,629Edgar G. Engleman · Stanford University · R01 · FY2022 · CA
siRNA Protection of Islet Grafts in Baboons
$523,568Anna Moore · Massachusetts General Hospital · R01 · FY2016 · DK
siRNA Protection of Islet Grafts in Baboons
$523,568Anna Moore · Massachusetts General Hospital · R01 · FY2015 · DK
Targeting iron metabolism in pancreatic adenocarcinoma to overcome KRAS inhibitor therapeutic resistance
$523,480Joseph D Mancias · Dana-Farber Cancer Inst · R01 · FY2025 · CA
Stephenson Cancer Center - Cancer Center Support Grant
$523,281Robert S Mannel · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2023 · CA
CIDR - GENOTYPING SERVICES USING ILLUMINA HUMAN METHYLATION EPIC ARRAY VERSION 2 (BLOOD) ON 1,495 EXPERIMENTAL DNA SAMPLES, NCI, HUANG
$523,250Kimberly F Doheny · Johns Hopkins University · N01 · FY2023 · HL
Contributions of the Adipose Tissue to the Development of Pancreatic Cancer
$523,133Zobeida Cruz-Monserrate · Ohio State University · R01 · FY2025 · CA
Sialylation-dependent mechanisms driving pancreatic cancer progression
$522,844Susan L Bellis · University Of Alabama At Birmingham · U01 · FY2021 · CA
Role of RABL6A-PP2A in neuroendocrine tumors
$522,600Dawn E Quelle · University Of Iowa · R01 · FY2022 · CA
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
$522,511Michael B Dwinell · Medical College Of Wisconsin · U01 · FY2015 · CA
Epidemiology of Cancer in a Cohort of Older Women
$522,496Aaron R Folsom · University Of Minnesota · R01 · FY2008 · CA
Oncogenic Met Signaling in Urologic Malignancies
$522,479Donald Bottaro · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Determinants and Measures of Smokeless Tobacco Use
$522,474Dorothy K Hatsukami · University Of Minnesota · R01 · FY2011 · CA
Integrative Molecular Profiling of Human Pancreatic Cancer
$522,435Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA